abrdn Life Sciences Investors (NYSE: HQL)
The Funds investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies.
Daily Data As of {{asOfDate}}
{{item.label}} {{item.value}} {{item.unit}}
Ticker symbol HQL (NYSE)
Gross Expense Ratio* 1.35%
Net Expense Ratio* 1.35%
* as of 09/30/2023
** as of 10/31/2024
Net assets** $454,332,807
Shares outstanding** 28,061,399
NAV Distribution Rate**11.64%
Fiscal year endedSeptember 30
Market Distribution Rate** 12.85%
The annual distribution rate an investor would receive if the most recent fund distribution and current fund price stayed the same going forward. It is calculated by annualizing the most recent distribution and dividing by the fund’s market price from the as-of-date. The distribution rate may include a return of capital. Please refer to the “Section 19 Notices” section of the fund’s website for the most recent Section 19 notice that provides estimated amounts and sources of the fund’s distributions, which should not be relied upon for tax reporting purposes.
Tax Information
Other fund announcements
Section 19 notices
View more information on the Fund's payments and composition of distributions